 Data describe a potent systemic immune response resulting in a significant reduction in challenge tumors and improvement in survival for UNO treated mice Challenge Tumor Take Challenge tumor take was markedly reduced in UNO treated mice vs the naïve control group Time Post Challenge Inoculation Days A significant survival advantage P 0.001 ... The post Beyond Cancer Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Conc... 